[1] Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. DOI:
10.1177/1060028018797110[2] PURNA MUKHERJEE. Thematic review series: sphingolipids. Ganglioside GM3 suppresses the proangiogenic effects of vascular endothelial growth factor and ganglioside GD1a.[J]. Journal of Lipid Research, 2008: 929-938. DOI:
10.1194/jlr.r800006-jlr200[3] THOMAS N SEYFRIED Purna M. Ganglioside GM3 Is Antiangiogenic in Malignant Brain Cancer.[J]. Journal of Oncology, 2010: 961243. DOI:
10.1155/2010/961243[4] KAZUYA KABAYAMA. Dissociation of the insulin receptor and caveolin-1 complex by ganglioside GM3 in the state of insulin resistance.[J]. Proceedings of the National Academy of Sciences of the United States of America, 2007, 104 34: 13678-13683. DOI:
10.1073/pnas.0703650104